Celltrion Healthcare has successfully secured a bid for cancer drug procurement held by the United Nations Development Programme (UNDP) and will supply Truxima (ingredient: rituximab) and Vegzelma (ingredient: bevacizumab).Truxima is a biosimilar referencing Biogen's Rituxan for treating blood cance
The Ministry of Food and Drug Safety (MFDS) has announced that South Korea has become one of three nations, alongside Switzerland and Singapore, officially listed on the World Health Organization's (WHO) first-round roster of WHO Listed Authorities (WLA).The WLA system is a recent initiative by WHO,
Illumina said it has unveiled an infographic titled "The Evolution of Illumina and Genomics" to celebrate its 25th anniversary. This infographic highlights the company's significant achievements and contributions to the field of genomics.Since its inception in 1998, Illumina has provided insights in
Merck Life Science said it signed a memorandum of understanding (MOU) with Daewoong Pharmaceutical to enhance AI-based new drug development.The strategic partnership aims to apply AI in the entire lifecycle of drug development.Under the accord, Daewoong will employ Merck's products to identify, vali
Curocell, a Korean CAR-T therapy maker, said it has set its final initial public offering (IPO) price at 20,000 won ($14.78), with the total offering amounting to 32 billion won.The company plans to invest the raised capital in the commercialization of its CD19 CAR-T (chimeric antigen receptor-T) th
KL& Partners, a Korean private equity firm, is in advanced talks to acquire Boryung Biopharma for an undisclosed sum.If the deal is finalized, it will mark approximately nine months since Boryung Biopharma was first put up for sale in February.According to industry sources, KL& Partners Consortium w
Researchers at the Catholic University of Korea College of Medicine have unveiled groundbreaking findings from their work using saponin-based nanoparticles, marking the first successful attempt to employ them in stem cell therapy for more efficient drug delivery and bone regeneration.The team, led b
Parents of children under the age of two will no longer bear out-of-pocket expenses if their child is hospitalized in Korea in 2024.The Ministry of Health and Welfare said that the partial amendment to the National Health Insurance Act, which includes such content, was approved in a cabinet meeting
Kakao Brain, a subsidiary of Korea's internet giant Kakao, and Ajou University Medical Center (AJMC) said they have signed a memorandum of understanding (MOU) to develop and enhance a mega-scale AI-based medical imaging diagnostic solution.Through this partnership, both organizations will focus on b
When treating rheumatoid arthritis, establishing insurance coverage guidelines regarding transitions between Janus kinase (JAK) inhibitors is urgently needed, a local rheumatology expert said. Professor Lee Sang-heon of the Rheumatology Department at Konkuk University Hospital spoke on the latest tr
A joint study by Gangnam Severance Hospital and the University of California San Francisco (UCSF) has discovered vital clues to enhance the precision of initial diagnosis for early-onset Alzheimer's.Typically, Alzheimer's disease (AD) symptoms appear in people over 65. However, an estimated 10 perce
Lunit said it has signed a research collaboration agreement with the University of Texas MD Anderson Cancer Center to analyze the use of MSD’s immunotherapy Keytruda (pembrolizumab) in multiple cancer types.Under the accord, Lunit and MD Anderson will use Lunit SCOPE IO, Lunit’s proprietary AI solut
Kolmar BNH, a Korean health supplement original development manufacturing (ODM), said the Ministry of Food and Drug Safety has recognized both fatigue improvement and immune enhancement capabilities for HemoHIM, a health functional food developed by the company.Introduced in 2006, HemoHIM was develo
The RIGHT (Research Investment for Global Health Technology) Foundation, Korea's first funding agency dedicated to supporting global health R&D via the Korean government, is poised to usher in a fresh wave of transformative health solutions."Beginning Nov. 1, the foundation is inviting proposals for
Lunit said it has become the first Korean company to participate in the Saudi Vision 2030 Healthcare Sandbox.The Healthcare Sandbox, initiated by the Saudi Arabian Ministry of Health in line with the Saudi Vision 2030 strategy, is designed to facilitate the digital transformation of the country's he
For the first time since its inception, Samsung Biologics' quarterly sales exceeded 1 trillion won ($740.7 million) in the third quarter, thanks to an increase in sales from the operation of its fourth factory and improved operational efficiency.Samsung Biologics announced Wednesday a consolidated r
In a strategic pivot, Medytox has altered its primary botulinum toxin (BTX) product to enter the Chinese market.According to the company, it recently decided to withdraw its drug registration application for Meditoxin (export name: Neuronox) with China's National Medical Products Administration (NMP
EDGC (Eone Diagnomics Genome Center) said has successfully completed its acquisition of GDXLab, a CLIA (Clinical Laboratory Improvement Amendments) certified lab located in the southern part of Denver, Colorado.The company believes that the acquisition is set to amplify EDGC's drive into the North A
The Ministry of Food and Drug Safety said it imposed an administrative penalty equivalent to a one-month suspension of clinical trials on Sanofi Pasteur Korea for the violation of labeling requirements in their ongoing meningococcal conjugate vaccine study.As a result of the violation of the Pharmac
Recognizing Takeda's Entyvio as an official rival of Celltrion's Zymfentra, Celltrion Group Chairman Seo Jung-jin unveiled the company's plans to conduct a head-to-head comparison study.Speaking at a press conference to discuss the recent approval of the company's merger by shareholders on Wednesday